Inga Hegemann

1.3k total citations
26 papers, 510 citations indexed

About

Inga Hegemann is a scholar working on Hematology, Genetics and Infectious Diseases. According to data from OpenAlex, Inga Hegemann has authored 26 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Inga Hegemann's work include Hemophilia Treatment and Research (12 papers), Iron Metabolism and Disorders (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Inga Hegemann is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Iron Metabolism and Disorders (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Inga Hegemann collaborates with scholars based in Switzerland, United States and Germany. Inga Hegemann's co-authors include Donat R. Spahn, Felix Schoenrath, Burkhardt Seifert, Alexander Kaserer, Gabriela H. Spahn, Volkmar Falk, Oliver M. Theusinger, Axel Hofmann, Philipp Stein and Francesco Maisano and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Inga Hegemann

23 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inga Hegemann Switzerland 13 241 180 78 74 71 26 510
C. Elliott United Kingdom 5 232 1.0× 145 0.8× 89 1.1× 48 0.6× 22 0.3× 6 455
Mary Guilfoyle United States 10 347 1.4× 342 1.9× 48 0.6× 64 0.9× 11 0.2× 11 592
Leonard I. Boral United States 12 172 0.7× 95 0.5× 50 0.6× 39 0.5× 16 0.2× 26 403
Emmanuelle Jeanpierre France 12 106 0.4× 41 0.2× 29 0.4× 48 0.6× 53 0.7× 33 408
Karén Matevosyan United States 13 176 0.7× 47 0.3× 90 1.2× 71 1.0× 9 0.1× 20 459
J Burger Switzerland 6 363 1.5× 147 0.8× 87 1.1× 21 0.3× 28 0.4× 9 531
Debra Masel United States 14 512 2.1× 494 2.7× 74 0.9× 12 0.2× 18 0.3× 25 816
Francesca Marangoni Italy 9 387 1.6× 295 1.6× 86 1.1× 42 0.6× 4 0.1× 18 577
Rachel Rayment United Kingdom 9 351 1.5× 52 0.3× 137 1.8× 62 0.8× 6 0.1× 14 636
D. Frei Switzerland 8 229 1.0× 200 1.1× 49 0.6× 40 0.5× 4 0.1× 16 462

Countries citing papers authored by Inga Hegemann

Since Specialization
Citations

This map shows the geographic impact of Inga Hegemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Hegemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Hegemann more than expected).

Fields of papers citing papers by Inga Hegemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga Hegemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Hegemann. The network helps show where Inga Hegemann may publish in the future.

Co-authorship network of co-authors of Inga Hegemann

This figure shows the co-authorship network connecting the top 25 collaborators of Inga Hegemann. A scholar is included among the top collaborators of Inga Hegemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga Hegemann. Inga Hegemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hegemann, Inga, et al.. (2024). Role of Piezo1 in Terminal Density Reversal of Red Blood Cells. Cells. 13(16). 1363–1363. 1 indexed citations
3.
4.
Hegemann, Inga, et al.. (2023). Management of abdominal pseudotumours in haemophilia: a systematic review. Swiss Medical Weekly. 153(8). 40094–40094.
5.
Mahlangu, Johnny, Daniel R Malan, Silva Zupančić Šalek, et al.. (2022). A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. British Journal of Haematology. 200(2). 229–239. 28 indexed citations
6.
Petrushanko, Irina Yu., et al.. (2021). Donor Age and Red Cell Age Contribute to the Variance in Lorrca Indices in Healthy Donors for Next Generation Ektacytometry: A Pilot Study. Frontiers in Physiology. 12. 639722–639722. 18 indexed citations
7.
Négrier, Claude, MV Ragni, Inga Hegemann, et al.. (2021). Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study. Hämostaseologie. 1 indexed citations
8.
Hegemann, Inga, Greta Simionato, Viviana Clavería, et al.. (2020). A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment. SHILAP Revista de lepidopterología. 1(1). 23–34. 14 indexed citations
9.
Casini, Alessandro, Lorenzo Alberio, Anne Angelillo‐Scherrer, et al.. (2020). Thromboprophylaxis and laboratory monitoring for in-hospital patients with Covid-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss Medical Weekly. 150. w20247–w20247. 69 indexed citations
10.
Arlettaz, Romaine, et al.. (2020). Neonatal red blood cell transfusion practices in Switzerland: national survey and review of international recommendations. Swiss Medical Weekly. 150(102). w20178–w20178. 2 indexed citations
11.
Fontana, Pierre, Lorenzo Alberio, Manuela Albisetti, et al.. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss Medical Weekly. 150(5153). w20422–w20422. 14 indexed citations
12.
Alberio, Lorenzo, Anne Angelillo‐Scherrer, Lars M. Asmis, et al.. (2020). Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland. Swiss Medical Weekly. 150. w20210–w20210. 16 indexed citations
13.
Rössler, Julian, Inga Hegemann, Felix Schoenrath, et al.. (2020). Efficacy of quadruple treatment on different types of pre‐operative anaemia: secondary analysis of a randomised controlled trial. Anaesthesia. 75(8). 1039–1049. 12 indexed citations
14.
Ettingshausen, Carmen Escuriola, Inga Hegemann, Mindy Simpson, et al.. (2019). Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial. Research and Practice in Thrombosis and Haemostasis. 3(2). 268–276. 14 indexed citations
15.
Hegemann, Inga, et al.. (2019). Evaluation of N8-GP Activity Using a One-Stage Clotting Assay: A Single-Center Experience. Acta Haematologica. 143(5). 504–508. 3 indexed citations
16.
Spahn, Donat R., Felix Schoenrath, Gabriela H. Spahn, et al.. (2019). Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. The Lancet. 393(10187). 2201–2212. 221 indexed citations
17.
Ragni, Margaret V., Pencho Georgiev, Michael Desmond Creagh, et al.. (2018). The Role of Antithrombin Lowering in Patients with Hemophilia: Hemostatic Control Pre- and Post-Fitusiran Dosing Interruption. Blood. 132(Supplement 1). 2477–2477. 2 indexed citations
18.
19.
20.
Dettmer, Matthias S., Inga Hegemann, & Stefan Hegemann. (2010). Extraintestinal Crohn’s Disease Mimicking Autoimmune Inner Ear Disease: A Histopathological Approach. Audiology and Neurotology. 16(1). 36–40. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Elliott Breakdown of academic impact, for papers by Mary Guilfoyle Breakdown of academic impact, for papers by Leonard I. Boral Breakdown of academic impact, for papers by Emmanuelle Jeanpierre Breakdown of academic impact, for papers by Karén Matevosyan Breakdown of academic impact, for papers by J Burger Breakdown of academic impact, for papers by Debra Masel Breakdown of academic impact, for papers by Francesca Marangoni Breakdown of academic impact, for papers by Rachel Rayment Breakdown of academic impact, for papers by D. Frei
Rankless by CCL
2026